# Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort

> **NCT01700959** · PHASE3 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 911 (actual)

## Conditions studied

- Cancer Malignancies

## Interventions

- **DRUG:** melatonin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01700959
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-06
- **Primary completion:** 2017-04-19
- **Final completion:** 2017-04-19
- **Target enrollment:** 911 (ACTUAL)
- **Last updated:** 2018-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01700959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01700959, "Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01700959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*